United StatesStand No: 3C60
AbbVie Contract Manufacturing has a portfolio of state-of-the-art facilities, offering a broad range of capabilities in North America and Europe. For more than 30 years, AbbVie Contract Manufacturing has offered contract manufacturing services that spans biologics, potent, drug product, prefilled syringes, fermentation, as well as selling high quality active pharmaceutical ingredients (APIs).
CanadaStand No: 3A78
Altasciences Clinical Research encompasses Algorithme Pharma in Montreal, QC, Vince & Associates Clinical Research in Overland Park, KS, as well as Algorithme Pharma USA in Fargo, ND, thereby making it one of the largest early phase clinical CROs in North America. With over 25 years of industry experience, Altasciences provides early phase clinical development services to an international customer base of biopharmaceutical and generic companies. Altasciences' full-service solutions offering in this critical stage of drug development includes medical writing, biostatistics, data management and bioanalysis.
United StatesStand No: 3A51
Avara offers contract manufacturing of APIs, solid and liquid sterile drug product, and packaging from five world-class facilities. Led by highly experienced industry veterans, Avara understands clients' individual needs and focuses on providing an exceptional outsourcing experience by delivering on commitments in terms of scope, schedule, compliance and price.
NetherlandsStand No: 3A100
Avivia is an independent specialized pharmaceutical development company engaged in drug repositioning, repurposing and reformulation. Our expertise and capabilities are centered around the development of value-added generic drugs, life cycle management of branded drug products, and complex formulation and CMC development of new drug products (NCE). We operate a hybrid business model combining CRO service activities with internal product development programs, whereby in both cases, we approach ‘development' as not just offering a technical solution but always part of a broader product-oriented strategy.
IndiaStand No: 3B72
Azidus CRO, based in Chennai, India. Conducts BA/BE studies (healthy volunteers and patients), clinical trials, clinical data management, pharmacovigilance and regulatory submission to the global drug regulatory agencies. 480 Bedded Clinical facility and bio-analytical facility with 26 LC-MS/MS and three ICPMS under one roof. Approved by ANVISA Brazil, inspected by USFDA, DCGI, MOH-Turkey, GLP-Poland, UAE, Chile Health Authority, submitted studies for Spain and Germany. Clinical Laboratory approved by CAP (College of American Pathologists) and NABL.
IndiaStand No: 3B100
Dorizoe Lifesciences Ltd is a purely Contract Research & Finished Product Development Organization based in India, working for Pharmaceutical Companies operating in Regulated Markets. We have strong capability in Finished Product Development of Parentral, Injectable (Lyophilized to Aqueous in Cytotoxic and Non Cytotoxic space) & Semi-Solids Like Creams, ointments & Gel in different delivery systems including Ampoules, Vials, PFS, PVC and Non - PVC bags and so on. At Dorizoe, we have very strong capability of developing injectables in cytotoxic to non cytotoxic space in lyophilized to aqueous form. After developing the product, we can also assist you for contract manufacturing by transferring the technology to your preferred CMO or at our recommended / preferred CMO partners. Apart from contract development, we also provide the Customized Services of Formulation and Development, Analytical Service, Quality Assurance, Regulatory Services and other Pharmaceutical Support Services. Currently we are working with the top pharmaceutical...
IrelandStand No: 3B80
NetherlandsStand No: 3A92
InnoSyn offers a team of passionate & experienced problem solvers, applying innovative and cost-efficient technologies such as flow chemistry, bio- and chemo-catalysis. If you need a scalable route for your new chemical compound (INVENT), or a better yield of your current product (IMPROVE), or manufacturing capacity for your product (IMPLEMENT), InnoSyn can help.
PolandStand No: 3A80
Institute of Industrial Organic Chemistry Branch Pszczyna is a pre-clinical contract research organization specializing in toxicological and ecotoxicological studies. As a GLP (Good Laboratory Practice) certified Institute we provide a wide range of services in the fields of human health protection and environmental safety, conduct studies of: plant protection products, pharmaceutical products, veterinary medical products, food and feed additives, industrial chemicals, biocides and industrial wastes. IPO offers research services in compliance with international guidelines: OECD, EU, EPPO, EMA, US EPA, SETAC/IOBC/BART/EPPO and ISO.
GermanyStand No: 3B70
Lichtenheldt is the committed full service pharmaceutical contract manufacturer and developer for non-sterile liquid and semi-solid dosage forms. Our manufacturing plant is accredited according to EU GMP and DIN EN ISO 13485 for medical products. Lichtenheldt has an ex proof production zone, store capabilities. Production and packaging under protective atmosphere is also possible. Our packaging expertise ranges from bottles, canisters, IBC bulk containers, tubes to stick packs. In addition to our manufacturing service we offer a wide range of additional service like analytical testing, galenic development, feasibility studies and regulatory services. Lichtenheldt has over 30 years of experience as a trustworthy contract manufacturer. We are the CMO-Expert for liquid and semi solids production and a first choice strategic outsourcing partner, so let's come together.
United StatesStand No: 3A60
Lifecore has 25 years of aseptic filling experience, focused on viscous and difficult to fill solutions. "Lifecore's" expertise grew from supplying sodium hyaluronate (hyaluronic acid) as an API to its partners and then supplying them with formulation, aseptic filling, and packaging services. Lifecore also does upstream manufacturing for its partners. Lifecore offers the services you expect from a CDMO: Development, Formulation and Process Development, Analytical Method Development, Stability Testing, Technology Transfer, Equipment Design and Procurement, Pilot Batch Sizes for Syringe and Vial Configurations, Quality Systems Experience in Pharmaceutical and Medical Device Regulations, Regulatory Support Clinical and Commercial Manufacturing, Formulation, Sterile Filtration of Highly Viscous Solutions, Aseptic Filling into Syringes or Vials, Secondary Sterilization, Final Packaging, Global Supply Chain Management, Large, Efficient Batch Sizes.
RomaniaStand No: 3B90
Magistra C&C is a Romanian producer of pharmaceutical products. Our production lines for the manufacturing of tablets, coated tablets, suppositories, ovules, creams, ointments and gels, are GMP certified in a new facility established in 2008, updated for the newest requisites in the Pharmaceutical Industry. Besides our main involvement in the Romanian pharmaceutical market, we also export our own products in the Russian Federation, Armenia, Azerbaijan, Georgia, Ukraine, Belarus, etc. and we perform contract manufacturing for important names in the pharmaceutical field. With a vast experience in the field, Magistra C&C is your perfect partner, complying with all current EU regulations.
United StatesStand No: 3A61
Marken, the clinical subsidiary of UPS, is the only patient-centric clinical supply chain organization dedicated exclusively to the global pharmaceutical and life sciences industries, supporting over 49,000 investigator sites in more than 150 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life-saving pharmaceuticals, clinical trial supplies and specimen collection, Marken integrates standard, specialty and hybrid solutions to extend the reach of clinical trials to even the most remote, treatment-naive geographies. Our highly-trained personnel, expansive facility network and complementary technology solutions bridge the distance between patients and the essential resources of life science companies.
ItalyStand No: 3C70
Mipharm S.p.A. was born in January 1998 following the merger of Sandoz and Ciba Geigy, from which resulted the new company Novartis. Mipharm was founded by a group of ex managers coming from Novartis by mean of a spin-off of the manufacturing site located in Milan, Via Quaranta, previously owned by Sandoz. In December 2016, Mandarin Capital Partners II acquired the majority stake in Mipharm share capital. Today, Mipharm is one of the most valuable third party manufacturing and new product development sites in Italy and it claims to have four FDA approvals (Nasal Spray Solution, Oral Potent Drug, Sachet, Packaging). Mipharm has been investing significant resources to continuously improve manufacturing site qualitative standard and currently it is able to produce and to pack a huge range of products and pharmaceutical forms.
IndiaStand No: 3A52
Panexcell is a well-established BA/BE centre at Mumbai, INDIA with total Bed Capacity of 58 and 21 CFR, Part 11 compliant sophisticated instruments like LCMS - API 5500. Panexcell have a comprehensive total quality management systems, standard processes specifically designed for high-quality deliverables, a sustained and reliable regulatory environment, and highly trained manpower. Services Offered in BA/BE: • Bio-Availability / Bio-Equivalence Studies • Pharmacokinetic Studies with NDDS and NCEs • Bio-analytical • Statistical Analysis • Data Management • Medical Writing • Special Population Studies Clinical Trials: • Proof of concept studies • Phase I - Phase IV Clinical studies • Disease prevalence and modality of the treatment • Safety monitoring • Pharmacovigilance • Therapeutic training Medical Writing: Our Medical writing team supports the planning and conduct of studies with utmost focus on safety. Their role comprises protocol designing, interacting with key operation leaders in specific therapeutic areas to obtain their...
ItalyStand No: 3C62
Since 2005 PolyCrystalline provides reliable solutions to optimise and control the crystallisation process of Active Pharmaceutical Ingredients for pharmaceutical companies. Our mission is to support our clients during drug development, helping them to reduce batch failure, avoiding costly crystallisation issues and overall offering greater confidence in drug quality during manufacturing. We can support you from early-phase drug discovery to kilogram supply. We are a high performing cohesive team of trained chemists and analysts, with more than 10 years of experience in the development and optimization of APIs crystallization. We care about results and innovation based on sound science and the use of modern technologies.
Czech RepublicStand No: 3B82
Quinta-Analytica is a leading Central and East European contract research organization located in Prague, Czech Republic, whose primary task is to supply pharmaceutical companies with comprehensive analytical and clinical services. For both small molecules and biopharmaceuticals, Quinta-Analytica offers the following services: analytical methods development; validation and transfer for the evaluation of drug substances; intermediates and/or pharmaceutical products; also including chiral separation and impurity isolation and identification; quality control and release testing; stability studies; clinical trials; and pharmacokinetic/toxicokinetic studies in man and/or animals. Quinta-Analytica operates in full compliance with GCP/GLP/GMP and FDA standards.
IndiaStand No: 3A83
Raptim Research Ltd. is a quality-oriented full-service contract (clinical) research organization. Raptim provides end-to-end services to global Pharmaceutical (generic as well as research-based), Biotechnology and Cosmetic industry. The studies done at Raptim are globally submitted and approved by various regulatory agencies including USFDA, EMA, UK MHRA, Canada (TPD), WHO and etc. Raptim Research Ltd., incorporated in the year 2005, has its facilities based in Navi Mumbai and Business Office in Navi Mumbai as well as New Jersey, USA. Raptim is leader following activities: Bioequivalence / Bioavailability Studies (BE/BA studies) PK end-point studies PD end-point studies Clinical trials – phase II & IV Studies on Special Population Apart from the above, Raptim has developed expertise in niche area of drug development and has pioneered in testing/screening Dermal Topical Products including Cosmetic Products as well as inhalation products. These include: In vitro Release/Permeation (IVRT/IVPT) studies In vivo – Tape Stripping studies In...
IndiaStand No: 3A74
Synchron is India's first internationally recognized Contract Research Organization, which started its operations in 1998. Synchron undertakes Phase I to IV Clinical trials, Bio-equivalence studies, Therapeutic equivalence studies & Pk/Pd studies. We have a robust experience of conducting BE studies with the facility being audited by the regulatory agencies like MHRA, US-FDA, AFFSAPS, MoH Turkey & DCG(I). We are among the first few CROs, who initiated conduct of Phase II to IV Clinical trials in India, initially as a partner to globally recognized CRO PAREXEL, and then managing multi-centric Clinical trials on our own.
IndiaStand No: 3A50
TherDose was initially built with a vision of creating a technology and therapeutic area research based speciality pharmaceutical company. With core expertise in the area of dosage form design and development, we are uniquely positioned to rapidly develop value added therapeutics that make a difference in people's lives. We are currently operating a partnership based model where we develop and commercialize dosage forms with corporate partners located worldwide. We specialize in developing/using drug delivery/formulation technologies that provide the highest therapeutic differentiation. After clearly establishing ourselves as a reputed R&D company, now we're envisaging the opportunities in the area of manufacturing oncology injectables, which are categorized as speciality segments, for distributing them worldwide at the most affordable prices.
GermanyStand No: 3A75
World Courier is the most trusted, global specialty logistics company in the world. Our services and solutions include a global network of 140+ offices in 50+ countries and 14 depots, clinical trial logistics, temperature control solutions, GxP compliance and pharmaceutical storage and distribution
BelgiumStand No: 3A90
Xedev is a contract development company in early stage feasibility Particle Engineering by Agglomeration / Coating / Drying. Fields of experitise are; Microencapsulation, Solid Dispersions, Controlled Release, Particle Agglomeration and Drying Development. Xedev's key to success is based on the combination of know-how in equipment engineering, process and product. The available technologies; spray dryer, fluid bed, high shear granulator, vacuum dryer, microwave dryer, nutsche filter, extruder spheroniser, homogeniser, tablet/capsule coater. Through partnerships are available; GMP infrastructure, Pre-clinical phase II, Analytical Dev, Stability and Bioequivalaent studies, Regulatory, Scale-up to pilot and production.